Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
J Allergy Clin Immunol. 2019 Jan;143(1):155-172. doi: 10.1016/j.jaci.2018.08.022. Epub 2018 Sep 5.
J Allergy Clin Immunol. 2019.
PMID: 30194992
Free article.
Clinical Trial.